1. Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum.
- Author
-
Joseph S, Sabulal B, George V, Antony KR, and Janardhanan KK
- Subjects
- Animals, Anti-Inflammatory Agents chemistry, Anti-Inflammatory Agents isolation & purification, Anti-Inflammatory Agents therapeutic use, Antineoplastic Agents chemistry, Antineoplastic Agents isolation & purification, Antineoplastic Agents therapeutic use, Carrageenan toxicity, Cell Line, Tumor, Dose-Response Relationship, Drug, Drug Evaluation, Preclinical, Drug Screening Assays, Antitumor, Edema chemically induced, Formaldehyde toxicity, Freeze Drying, Fruit, Humans, Male, Mice, Neoplasms prevention & control, Phytotherapy, Plant Preparations isolation & purification, Plant Preparations pharmacology, Polysaccharides chemistry, Polysaccharides isolation & purification, Polysaccharides therapeutic use, Anti-Inflammatory Agents pharmacology, Antineoplastic Agents pharmacology, Edema drug therapy, Neoplasms drug therapy, Polysaccharides pharmacology, Reishi chemistry
- Abstract
In this study, polysaccharides were isolated from Ganoderma lucidum (Polyporaceae) and their antitumor and anti-inflammatory activities were investigated using in vivo models. Potential antitumor activity was shown by G. lucidum polysaccharides (GLP) against solid tumor induced by Ehrlich's ascites carcinoma cells. GLP at 100 mg kg(-1) body mass showed 80.8 and 77.6% reduction in tumour volume and tumour mass, respectively, when administered 24 h after tumour implantation. Again, GLP at the same dose but when administered prior to tumour inoculation, showed 79.5 and 81.2% inhibition of tumour volume and tumour mass, respectively. GLP showed significant dose-dependent activity in carrageenean-induced (acute) and formalin-induced (chronic) inflammation assays. At 100 mg kg(-1), GLP exhibited 57.6 and 58.2% inhibition in carrageenean-induced and formalin-induced assays, respectively. more...
- Published
- 2011
- Full Text
- View/download PDF